Skip to main content
Top
Published in: Journal of Neurology 2/2016

01-02-2016 | Original Communication

Pseudobulbar affect (PBA) in an incident ALS cohort: results from the Apulia registry (SLAP)

Authors: Rosanna Tortelli, Massimiliano Copetti, Simona Arcuti, Marianna Tursi, Annalisa Iurillo, Maria Rosaria Barulli, Rosa Cortese, Rosa Capozzo, Eustachio D’Errico, Benoit Marin, Isabella Laura Simone, Giancarlo Logroscino

Published in: Journal of Neurology | Issue 2/2016

Login to get access

Abstract

The aim of this study is to investigate the frequency and the clinical correlations of pseudobulbar affect (PBA) in a population-based incident cohort of ALS patients. Incident ALS cases, diagnosed in 2011 and 2012, according to El Escorial criteria were enrolled from a prospective population-based registry in Apulia, Southern Italy. Neurological status was assessed using a standard neurological examination and the revised ALS Functional Rating Scale (ALSFRSr). The Center for Neurologic Study-Lability Scale (CNS-LS), a self-administered questionnaire, was used to evaluate the presence and severity of PBA. Total scores range from 7 to 35. A score ≥13 was used to identify the presence of PBA. One-hundred thirty-two sporadic incident ALS cases were enrolled. Median disease duration was 20 months (range 2–143), median onset-diagnosis interval (ODI) 12 months (range 2–131), median ALSFRSr at baseline 36/48 (range 2–47) and median ALSFRSr bulbar sub-score 10/12 (range 0–12). Neurological examination revealed presence of PBA in 34/132 patients (26 %). Pathological CNS-LS score was found in 45/132 patients (34 %). Median total CNS-LS score was 9/35 (range 7–29). The subgroup with pathological CNS-LS was characterized by a short disease duration from symptom onset, ODI, time to diffusion to a second region, time to generalization and ALSFRSr bulbar sub-score, bulbar onset, “definite” diagnostic category, bulbar upper motor-neuron involvement and presence of PBA at neurological examination. In population-based setting, one-third of ALS patients present PBA at diagnosis. The presence of PBA is associated with bulbar UMN involvement and markers of a more severe phenotype.
Literature
1.
go back to reference Dark FL, McGrath JJ, Ron MA (1996) Pathological laughing and crying. Aust N Z J Psychiatry 30:472–479CrossRefPubMed Dark FL, McGrath JJ, Ron MA (1996) Pathological laughing and crying. Aust N Z J Psychiatry 30:472–479CrossRefPubMed
2.
go back to reference Starkstein SE, Migliorelli R, Tesón A et al (1995) Prevalence and clinical correlates of pathological affective display in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 59:55–60CrossRefPubMedPubMedCentral Starkstein SE, Migliorelli R, Tesón A et al (1995) Prevalence and clinical correlates of pathological affective display in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 59:55–60CrossRefPubMedPubMedCentral
3.
go back to reference Miller RG, Rosenberg JA, Gelinas DF et al (1999) Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology 52:1311–1323CrossRefPubMed Miller RG, Rosenberg JA, Gelinas DF et al (1999) Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology 52:1311–1323CrossRefPubMed
4.
go back to reference Miller RG, Jackson CE, Kasarskis EJ et al (2009) Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 73:1227–1233CrossRefPubMedPubMedCentral Miller RG, Jackson CE, Kasarskis EJ et al (2009) Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 73:1227–1233CrossRefPubMedPubMedCentral
5.
go back to reference Gallagher JP (1989) Pathologic laughter and crying in ALS: a search for their origin. Acta Neurol Scand 80:114–117CrossRefPubMed Gallagher JP (1989) Pathologic laughter and crying in ALS: a search for their origin. Acta Neurol Scand 80:114–117CrossRefPubMed
6.
go back to reference Work SS, Colamonico JA, Bradley WG, Kaye RE (2011) Pseudobulbar affect: an under-recognized and under-treated neurological disorder. Adv Ther 28(7):586–601CrossRefPubMed Work SS, Colamonico JA, Bradley WG, Kaye RE (2011) Pseudobulbar affect: an under-recognized and under-treated neurological disorder. Adv Ther 28(7):586–601CrossRefPubMed
7.
go back to reference Floeter MK, Katipally R, Kim MP et al (2014) Impaired corticopontocerebellar tracts underlie pseudobulbar affect in motor neuron disorders. Neurology 83(7):620–627CrossRefPubMedPubMedCentral Floeter MK, Katipally R, Kim MP et al (2014) Impaired corticopontocerebellar tracts underlie pseudobulbar affect in motor neuron disorders. Neurology 83(7):620–627CrossRefPubMedPubMedCentral
8.
go back to reference Lichtner V, Dowding D, Esterhuizen P et al (2014) Pain assessment for people with dementia: a systematic review of systematic reviews of pain assessment tools. BMC Geriatr 14(1):138CrossRefPubMedPubMedCentral Lichtner V, Dowding D, Esterhuizen P et al (2014) Pain assessment for people with dementia: a systematic review of systematic reviews of pain assessment tools. BMC Geriatr 14(1):138CrossRefPubMedPubMedCentral
9.
10.
go back to reference Robinson RG, Parikh RM, Lipsey JR, Starkstein SE, Price TR (1993) Pathological laughing and crying following stroke: validation of a measurement scale and a double-blind treatment study. Am J Psychiatry 150(2):286–293CrossRefPubMed Robinson RG, Parikh RM, Lipsey JR, Starkstein SE, Price TR (1993) Pathological laughing and crying following stroke: validation of a measurement scale and a double-blind treatment study. Am J Psychiatry 150(2):286–293CrossRefPubMed
11.
go back to reference Brooks BR (1994) El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial “Clinical limits of amyotrophic lateral sclerosis” workshop contributors. J Neurol Sci 124(Suppl):96–107CrossRefPubMed Brooks BR (1994) El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial “Clinical limits of amyotrophic lateral sclerosis” workshop contributors. J Neurol Sci 124(Suppl):96–107CrossRefPubMed
12.
go back to reference Logroscino G, Beghi E, Zoccolella S et al (2005) SLAP registry. Incidence of amyotrophic lateral sclerosis in Southern Italy: a population-based study. J Neurol Neurosurg Psychiatry 76:1094–1098CrossRefPubMedPubMedCentral Logroscino G, Beghi E, Zoccolella S et al (2005) SLAP registry. Incidence of amyotrophic lateral sclerosis in Southern Italy: a population-based study. J Neurol Neurosurg Psychiatry 76:1094–1098CrossRefPubMedPubMedCentral
13.
go back to reference Cedarbaum JM, Stambler N, Malta E et al (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 169:13–21CrossRefPubMed Cedarbaum JM, Stambler N, Malta E et al (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 169:13–21CrossRefPubMed
14.
go back to reference Newsom-Davis IC, Abrahams S, Goldstein LH, Leigh PN (1999) The emotional lability questionnaire: a new measure of emotional lability in amyotrophic lateral sclerosis. J Neurol Sci 169(1–2):22–25CrossRefPubMed Newsom-Davis IC, Abrahams S, Goldstein LH, Leigh PN (1999) The emotional lability questionnaire: a new measure of emotional lability in amyotrophic lateral sclerosis. J Neurol Sci 169(1–2):22–25CrossRefPubMed
15.
go back to reference Ravits J, Laurie P, Fan Y, Moore DH (2007) Implications of ALS focality: rostral-caudal distribution of lower motor neuron loss postmortem. Neurology 68:1576–1582CrossRefPubMed Ravits J, Laurie P, Fan Y, Moore DH (2007) Implications of ALS focality: rostral-caudal distribution of lower motor neuron loss postmortem. Neurology 68:1576–1582CrossRefPubMed
17.
go back to reference Logroscino G, Traynor BJ, Hardiman O, EURALS et al (2008) Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry 79(1):6–11CrossRefPubMed Logroscino G, Traynor BJ, Hardiman O, EURALS et al (2008) Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry 79(1):6–11CrossRefPubMed
18.
go back to reference Palmieri A, Abrahams S, Sorarù G et al (2009) Emotional lability in MND: relationship to cognition and psychopathology and impact on caregivers. J Neurol Sci 278(1–2):16–20CrossRefPubMed Palmieri A, Abrahams S, Sorarù G et al (2009) Emotional lability in MND: relationship to cognition and psychopathology and impact on caregivers. J Neurol Sci 278(1–2):16–20CrossRefPubMed
19.
go back to reference Montuschi A, Iazzolino B, Calvo A et al (2015) Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. J Neurol Neurosurg Psychiatry 86(2):168–173CrossRefPubMed Montuschi A, Iazzolino B, Calvo A et al (2015) Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. J Neurol Neurosurg Psychiatry 86(2):168–173CrossRefPubMed
20.
go back to reference Phukan J, Elamin M, Bede P et al (2012) The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry 83(1):102–108CrossRefPubMed Phukan J, Elamin M, Bede P et al (2012) The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry 83(1):102–108CrossRefPubMed
21.
go back to reference Consonni M, Iannaccone S, Cerami C et al (2013) The cognitive and behavioural profile of amyotrophic lateral sclerosis: application of the consensus criteria. Behav Neurol 27(2):143–153CrossRefPubMedPubMedCentral Consonni M, Iannaccone S, Cerami C et al (2013) The cognitive and behavioural profile of amyotrophic lateral sclerosis: application of the consensus criteria. Behav Neurol 27(2):143–153CrossRefPubMedPubMedCentral
22.
go back to reference McCullagh S, Moore M, Gawel M, Feinstein A (1999) Pathological laughing and crying in amyotrophic lateral sclerosis: an association with prefrontal cognitive dysfunction. J Neurol Sci 169(1–2):43–48CrossRefPubMed McCullagh S, Moore M, Gawel M, Feinstein A (1999) Pathological laughing and crying in amyotrophic lateral sclerosis: an association with prefrontal cognitive dysfunction. J Neurol Sci 169(1–2):43–48CrossRefPubMed
23.
go back to reference Parvizi J, Coburn KL, Shillcutt SD, Coffey CE, Lauterbach EC, Mendez MF (2009) Neuroanatomy of pathological laughing and crying: a report of the American Neuropsychiatric Association Committee on Research. J Neuropsychiatry Clin Neurosci 21(1):75–87CrossRefPubMed Parvizi J, Coburn KL, Shillcutt SD, Coffey CE, Lauterbach EC, Mendez MF (2009) Neuroanatomy of pathological laughing and crying: a report of the American Neuropsychiatric Association Committee on Research. J Neuropsychiatry Clin Neurosci 21(1):75–87CrossRefPubMed
24.
go back to reference Pioro EP, Brooks BR, Cummings J, Safety, Tolerability, and Efficacy Results Trial of AVP-923 in PBA Investigators et al (2010) Dextromethorphan plus ultra low-dose quinidine reduces pseudobulbar affect. Ann Neurol. 68(5):693–702CrossRefPubMed Pioro EP, Brooks BR, Cummings J, Safety, Tolerability, and Efficacy Results Trial of AVP-923 in PBA Investigators et al (2010) Dextromethorphan plus ultra low-dose quinidine reduces pseudobulbar affect. Ann Neurol. 68(5):693–702CrossRefPubMed
25.
go back to reference Seliger GM, Hornstein A (1989) Serotonin, fluoxetine, and pseudobulbar affect. Neurology 39(10):1400CrossRefPubMed Seliger GM, Hornstein A (1989) Serotonin, fluoxetine, and pseudobulbar affect. Neurology 39(10):1400CrossRefPubMed
26.
go back to reference Schoedel KA, Pope LE, Sellers EM (2012) Randomized open-label drug-drug interaction trial of dextromethorphan/quinidine and paroxetine in healthy volunteers. Clin Drug Investig 32(3):157–169CrossRefPubMed Schoedel KA, Pope LE, Sellers EM (2012) Randomized open-label drug-drug interaction trial of dextromethorphan/quinidine and paroxetine in healthy volunteers. Clin Drug Investig 32(3):157–169CrossRefPubMed
27.
go back to reference Wortzel HS, Oster TJ, Anderson CA, Arciniegas DB (2008) Pathological laughing and crying: epidemiology, pathophysiology and treatment. CNS Drugs 22(7):531–545CrossRefPubMed Wortzel HS, Oster TJ, Anderson CA, Arciniegas DB (2008) Pathological laughing and crying: epidemiology, pathophysiology and treatment. CNS Drugs 22(7):531–545CrossRefPubMed
28.
go back to reference Colamonico J, Formella A, Bradley W (2012) Pseudobulbar affect: burden of illness in the USA. Adv Ther 29(9):775–798CrossRefPubMed Colamonico J, Formella A, Bradley W (2012) Pseudobulbar affect: burden of illness in the USA. Adv Ther 29(9):775–798CrossRefPubMed
29.
go back to reference Brooks BR, Crumpacker D, Fellus J, Kantor D, Kaye RE (2013) PRISM: a novel research tool to assess the prevalence of pseudobulbar affect symptoms across neurological conditions. PLoS ONE 8(8):e72232CrossRefPubMedPubMedCentral Brooks BR, Crumpacker D, Fellus J, Kantor D, Kaye RE (2013) PRISM: a novel research tool to assess the prevalence of pseudobulbar affect symptoms across neurological conditions. PLoS ONE 8(8):e72232CrossRefPubMedPubMedCentral
Metadata
Title
Pseudobulbar affect (PBA) in an incident ALS cohort: results from the Apulia registry (SLAP)
Authors
Rosanna Tortelli
Massimiliano Copetti
Simona Arcuti
Marianna Tursi
Annalisa Iurillo
Maria Rosaria Barulli
Rosa Cortese
Rosa Capozzo
Eustachio D’Errico
Benoit Marin
Isabella Laura Simone
Giancarlo Logroscino
Publication date
01-02-2016
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 2/2016
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-015-7981-3

Other articles of this Issue 2/2016

Journal of Neurology 2/2016 Go to the issue